Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Zfyve28 | Rat | 1,2-dichloroethane | increases expression | ISO | Zfyve28 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of ZFYVE28 mRNA | CTD | PMID:28960355 | Zfyve28 | Rat | 17beta-estradiol | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of ZFYVE28 mRNA | CTD | PMID:30165855 | Zfyve28 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Zfyve28 (Mus musculus) | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of ZFYVE28 mRNA | CTD | PMID:31388691 | Zfyve28 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFYVE28 mRNA | CTD | PMID:32109520 | Zfyve28 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Zfyve28 | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of ZFYVE28 gene | CTD | PMID:31601247 | Zfyve28 | Rat | 5-aza-2'-deoxycytidine | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Decitabine inhibits the reaction [Smoke results in decreased expression of ZFYVE28 mRNA] | CTD | PMID:21095227 | Zfyve28 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ZFYVE28 mRNA | CTD | PMID:24780913 | Zfyve28 | Rat | aflatoxin B1 | affects methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the methylation of ZFYVE28 intron | CTD | PMID:30157460 | Zfyve28 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of ZFYVE28 intron | CTD | PMID:30157460 | Zfyve28 | Rat | arsane | affects methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ZFYVE28 gene | CTD | PMID:25304211 | Zfyve28 | Rat | arsenic atom | affects methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ZFYVE28 gene | CTD | PMID:25304211 | Zfyve28 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of ZFYVE28 gene | CTD | PMID:28931070 | Zfyve28 | Rat | benzo[a]pyrene | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ZFYVE28 mRNA | CTD | PMID:20064835 | Zfyve28 | Rat | benzo[a]pyrene | decreases methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ZFYVE28 promoter | CTD | PMID:27901495 | Zfyve28 | Rat | benzo[a]pyrene | affects methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZFYVE28 intron | CTD | PMID:30157460 | Zfyve28 | Rat | benzo[e]pyrene | increases methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of ZFYVE28 intron | CTD | PMID:30157460 | Zfyve28 | Rat | beta-lapachone | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of ZFYVE28 mRNA | CTD | PMID:38218311 | Zfyve28 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ZFYVE28 mRNA | CTD | PMID:25181051|PMID:30816183 | Zfyve28 | Rat | bisphenol A | decreases methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of ZFYVE28 gene | CTD | PMID:31601247 | Zfyve28 | Rat | bisphenol F | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Zfyve28 | Rat | cadmium atom | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZFYVE28 more ... | CTD | PMID:34773240|PMID:35301059 | Zfyve28 | Rat | cadmium atom | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of ZFYVE28 mRNA | CTD | PMID:34773240 | Zfyve28 | Rat | cadmium dichloride | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of ZFYVE28 mRNA | CTD | PMID:38382870 | Zfyve28 | Rat | cadmium dichloride | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZFYVE28 more ... | CTD | PMID:35301059 | Zfyve28 | Rat | cisplatin | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ZFYVE28 mRNA | CTD | PMID:27392435 | Zfyve28 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of ZFYVE28 mRNA | CTD | PMID:26577399 | Zfyve28 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of ZFYVE28 mRNA | CTD | PMID:27523638 | Zfyve28 | Rat | dexamethasone | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Zfyve28 | Rat | elemental selenium | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Selenium inhibits the reaction [Cadmium results in decreased expression of ZFYVE28 mRNA] | CTD | PMID:34773240 | Zfyve28 | Rat | ethanol | affects expression | ISO | Zfyve28 (Mus musculus) | 6480464 | Ethanol affects the expression of ZFYVE28 mRNA | CTD | PMID:30319688 | Zfyve28 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of ZFYVE28 mRNA | CTD | PMID:30307764 | Zfyve28 | Rat | FR900359 | increases phosphorylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of ZFYVE28 protein | CTD | PMID:37730182 | Zfyve28 | Rat | fulvestrant | increases methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of ZFYVE28 gene | CTD | PMID:31601247 | Zfyve28 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of ZFYVE28 mRNA | CTD | PMID:33387578 | Zfyve28 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of ZFYVE28 gene | CTD | PMID:35440735 | Zfyve28 | Rat | hexadecanoic acid | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Palmitic Acid results in decreased expression of ZFYVE28 mRNA | CTD | PMID:39506029 | Zfyve28 | Rat | indometacin | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Zfyve28 | Rat | maneb | multiple interactions | ISO | Zfyve28 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of ZFYVE28 mRNA | CTD | PMID:36117858 | Zfyve28 | Rat | methapyrilene | increases methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of ZFYVE28 intron | CTD | PMID:30157460 | Zfyve28 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of ZFYVE28 gene | CTD | PMID:35440735 | Zfyve28 | Rat | methylmercury chloride | increases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of ZFYVE28 mRNA | CTD | PMID:28001369 | Zfyve28 | Rat | nickel atom | increases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Nickel results in increased expression of ZFYVE28 mRNA | CTD | PMID:25583101 | Zfyve28 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ZFYVE28 mRNA | CTD | PMID:33387578 | Zfyve28 | Rat | paraquat | multiple interactions | ISO | Zfyve28 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of ZFYVE28 mRNA | CTD | PMID:36117858 | Zfyve28 | Rat | perfluorohexanesulfonic acid | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ZFYVE28 mRNA | CTD | PMID:25812627 | Zfyve28 | Rat | perfluorohexanesulfonic acid | decreases expression | ISO | Zfyve28 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ZFYVE28 mRNA | CTD | PMID:37995155 | Zfyve28 | Rat | perfluorononanoic acid | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ZFYVE28 mRNA | CTD | PMID:25812627 | Zfyve28 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ZFYVE28 mRNA | CTD | PMID:25812627 | Zfyve28 | Rat | perfluorooctanoic acid | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of ZFYVE28 mRNA | CTD | PMID:25812627 | Zfyve28 | Rat | propanal | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of ZFYVE28 mRNA | CTD | PMID:26079696 | Zfyve28 | Rat | resveratrol | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of ZFYVE28 mRNA | CTD | PMID:23557933 | Zfyve28 | Rat | selenium atom | multiple interactions | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Selenium inhibits the reaction [Cadmium results in decreased expression of ZFYVE28 mRNA] | CTD | PMID:34773240 | Zfyve28 | Rat | silicon dioxide | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of ZFYVE28 mRNA | CTD | PMID:25895662 | Zfyve28 | Rat | sodium arsenite | decreases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ZFYVE28 mRNA | CTD | PMID:29301061 | Zfyve28 | Rat | sunitinib | increases expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ZFYVE28 mRNA | CTD | PMID:31533062 | Zfyve28 | Rat | Theaflavin 3,3'-digallate | affects expression | ISO | ZFYVE28 (Homo sapiens) | 6480464 | theaflavin-3,3'-digallate affects the expression of ZFYVE28 mRNA | CTD | PMID:34925699 | Zfyve28 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of ZFYVE28 mRNA | CTD | PMID:33387578 | Zfyve28 | Rat | triptonide | increases expression | ISO | Zfyve28 (Mus musculus) | 6480464 | triptonide results in increased expression of ZFYVE28 mRNA | CTD | PMID:33045310 | Zfyve28 | Rat | valproic acid | increases methylation | ISO | ZFYVE28 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ZFYVE28 gene | CTD | PMID:29154799 | Zfyve28 | Rat | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of ZFYVE28 mRNA | CTD | PMID:29427782 | Zfyve28 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of ZFYVE28 mRNA | CTD | PMID:19015723 | Zfyve28 | Rat | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of ZFYVE28 gene | CTD | PMID:31079544 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















